Introduction: Amyotrophic Lateral Sclerosis (ALS) is a progressive, incurable neurodegenerative disease that targets motoneurons. Cell-based therapies have generated widespread interest as a potential therapeutic approach but no conclusive results have yet been reported either from pre-clinical or clinical studies. Areas covered: This is an integrated review of pre-clinical and clinical studies focused on the development of cell-based therapies for ALS. We analyze the biology of stem cell treatments and results obtained from pre-clinical models of ALS and examine the methods and the results obtained to date from clinical trials. We discuss scientific, clinical, and ethical issues and propose some directions for future studies. Expert opinion: While data from individual studies are encouraging, stem-cell-based therapies do not yet represent a satisfactory, reliable clinical option. The field will critically benefit from the introduction of well-designed, randomized and reproducible, powered clinical trials. Comparative studies addressing key issues such as the nature, properties, and number of donor cells, the delivery mode and the selection of proper patient populations that may benefit the most from cell-based therapies are now of the essence. Multidisciplinary networks of experts should be established to empower effective translation of research into the clinic.

Mazzini, L., Ferrari, D., Andjus, P., Buzanska, L., Cantello, R., De Marchi, F., et al. (2018). Advances in stem cell therapy for amyotrophic lateral sclerosis. EXPERT OPINION ON BIOLOGICAL THERAPY, 18(8), 865-881 [10.1080/14712598.2018.1503248].

Advances in stem cell therapy for amyotrophic lateral sclerosis

Ferrari, Daniela
Secondo
;
Vescovi, Angelo L.
Ultimo
2018

Abstract

Introduction: Amyotrophic Lateral Sclerosis (ALS) is a progressive, incurable neurodegenerative disease that targets motoneurons. Cell-based therapies have generated widespread interest as a potential therapeutic approach but no conclusive results have yet been reported either from pre-clinical or clinical studies. Areas covered: This is an integrated review of pre-clinical and clinical studies focused on the development of cell-based therapies for ALS. We analyze the biology of stem cell treatments and results obtained from pre-clinical models of ALS and examine the methods and the results obtained to date from clinical trials. We discuss scientific, clinical, and ethical issues and propose some directions for future studies. Expert opinion: While data from individual studies are encouraging, stem-cell-based therapies do not yet represent a satisfactory, reliable clinical option. The field will critically benefit from the introduction of well-designed, randomized and reproducible, powered clinical trials. Comparative studies addressing key issues such as the nature, properties, and number of donor cells, the delivery mode and the selection of proper patient populations that may benefit the most from cell-based therapies are now of the essence. Multidisciplinary networks of experts should be established to empower effective translation of research into the clinic.
Articolo in rivista - Review Essay
Amyotrophic lateral sclerosis; animal models; cellular models; clinical trials; stem cells; transplantation;
Amyotrophic lateral sclerosis; animal models; cellular models; clinical trials; stem cells; transplantation; Pharmacology; Drug Discovery3003 Pharmaceutical Science; Clinical Biochemistry
English
2018
18
8
865
881
reserved
Mazzini, L., Ferrari, D., Andjus, P., Buzanska, L., Cantello, R., De Marchi, F., et al. (2018). Advances in stem cell therapy for amyotrophic lateral sclerosis. EXPERT OPINION ON BIOLOGICAL THERAPY, 18(8), 865-881 [10.1080/14712598.2018.1503248].
File in questo prodotto:
File Dimensione Formato  
6. ALS therapy Expert Opinion 2018.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 4.9 MB
Formato Adobe PDF
4.9 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/219057
Citazioni
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 26
Social impact